With Winrevair Approved, Merck Has A Chance To Execute On CV Strategy

The WAC price of Winrevair is $14,000 per vial

 
• By Jessica Merrill
  
pulmonary disease
Merck's sotatercept was approved by FDA for PAH • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip